A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Germany

NCT07494656 · clinicaltrials.gov ↗

RECRUITING

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

ATTR-CM (Transthyretin Amyloid Cardiomyopathy)

Interventions

OTHER: tafamidis 61mg (based on prescription data)

Sponsor

Pfizer